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Original Article
Purpose: This study aimed to investigate the influence of aerobic exercise on the quality of life and leptin and adiponectin levels in patients with 
type 2 diabetes mellitus. 
Material and Method: Patients were randomized into two groups: aerobic exercise-training and control group. Parameters were assessed 
at baseline and end of the twelve-week follow-up for 60 type 2 diabetic patients who completed the program. The 36-item Short Form Health 
Survey was administered to the patients. 
Results: The exercise-training group results showed a decrease in adiponectin and leptin levels, a reduction of waist circumference and 
percentage of body fat (p=0.007, 0.023, 0.012 and 0.048, respectively). The leptin levels in the aerobic exercise group were positively correlated 
with body mass index (r=0.303, p=0.021) and percentage of body fat (r=0.371, p=0.005); they were negatively correlated with physical problems 
(r=-0.482; p=0.009) and pain (r=-0.540; p=0.003). Exercise led to statistically significant improvements in the SF-36 physical functioning and 
mental health subscales (p=0.020 and 0.023, respectively). 
Discussion: The association of better HbA1c, waist circumference, and percentage of body fat with improved mental and physical scores may 
be related to a decrease in leptin levels, despite a significant reduction in serum adiponectin levels. Turk Jem 2015; 19: 7-13
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Amaç: Bu çalışmada tip 2 diyabetli hastalarda aerobik egzersizin serum leptin, adiponektin düzeylerine ve yaşam kalitesi üzerine etkisini 
değerlendirmeyi amaçladık. 
Gereç ve Yöntem: Hastalar 2 gruba randomize edildi: aerobik egzersiz ve kontrol grubu. Altmış tip 2 diyabetli hastanın parametreleri başlangıçta 
ve 12 haftalık program sonunda değerlendirildi. 
Bulgular: Egzersiz grubunda adiponektin, leptin düzeylerinde düşme, bel çevresinde ve vücut yağ oranında azalma gözlendi (sırasıyla p değerleri 
0,007, 0,023, 0,012, 0,048). Egzersiz grubunda leptin düzeyleri, Beden kitle indeksi (r=0,303, p=0,021), vücut yağ oranı (r=0,371, p=0,005) ile pozitif 
korelasyon, fizik problemlerle (r=-0,482; p=0,009) ve ağrı (r=-0,540; p=0,003) ile negatif korelasyon gösteriyordu. Aynı zamanda egzersiz, bir 
yaşam kalitesi ölçeği olan SF-36 anketinde fiziksel fonksiyon ve mental sağlık skalasında da anlamlı iyileşmeyle sonuçlandı (sırasıyla, p değerleri 
0,020, 0,023). 
Tartışma: Serum adiponektin düzeylerinde önemli ölçüde azalmaya rağmen, mental ve fiziksel skorlardaki iyileşme, HbA1c, bel çevresi ve vücut 
yağ oranındaki iyileşme azalan leptin düzeyleri ile ilişkili olabilir. Turk Jem 2015; 19: 7-13
Anah tar ke li me ler: Adiponektin, egzersiz, leptin, SF-36, tip 2 diyabet
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The incidence and prevalence of diabetes mellitus (DM) has been 
increasing in recent years (1). Type 2 DM (T2DM) is associated 
with insulin resistance and obesity resulting from genetic and 
environmental factors including the decrease of physical activity 
and the increase of calorie intake (2). Regular physical activity has 
a positive effect on insulin sensitivity, appetite, glycemic regulation, 
and control of body weight. Therefore, exercise is suggested as 
the primary first-line modality and is considered indispensable in 
the treatment of obesity and T2DM (3). However, the mechanisms 
underlying the beneficial effects of aerobic exercise that prevent 
cardiovascular disease and improve glycemic control are not 
entirely understood. 
Adiponectin (4) and leptin (5), two proteins secreted by adipose 
tissue, are implicated in insulin resistance, and they may play 
a role in the etiology of T2DM. Adiponectin has anti-diabetic, 
insulin-sensitizing, anti-inflammatory, and anti-atherogenic 
effects (6,7) and it may be used as a treatment strategy in the 
management of obesity, diabetes, and metabolic syndrome 
(4). Adiponectin also has beneficial actions in the control of 
the inflammatory process and atherogenesis on vascular 
endothelial function (7). We have little knowledge about the 
relationship between the improvement in insulin resistance 
induced by short-term aerobic exercise and adiponectin levels 
in T2DM. In the literature, a few reports have investigated the 
acute or chronic effects of short- and long-term physical activity 
on plasma adiponectin levels (8,9,10,11).
Leptin is produced by adipocytes and acts on the satiety center 
on the hypothalamus to suppress appetite, limit food intake and 
increase energy expenditure. A leptin-resistant/hyperleptinemic 
state has been demonstrated in obesity and obesity related 
cardiovascular disease (12). Furthermore, there was a significant 
association between insulin resistance and serum leptin 
concentrations (13). High serum leptin levels and low serum 
adiponectin levels have been demonstrated to be related to 
T2DM (4,5). The effect of exercise on circulating adiponectin 
remains inconclusive, with increases (14,15), decreases (8), and 
“no change” (9) reported in different studies. 
Several studies have shown that diabetic patients have a 
decreased quality of life (QOL) compared to healthy individuals 
(16). On the other hand, the relationship between glycemic 
control and QOL is unclear. A randomized controlled double-
blind trial showed that improved HbA1c was associated with 
short-term improvement in QOL and economic benefits in 
T2DM (17). Another study showed no association (18) in these 
parameters.
In this study, the relationship between aerobic exercise and 
QOL as measured by the SF-36 was evaluated before and after 
12 weeks of exercise. The major purpose of this study was to 
determine whether moderate-intensity exercise training would 
change leptin and adiponectin levels and whether leptin and 
adiponectin levels affect QOL. Another purpose was to determine 
if adults who regularly exercised had better QOL than those who 
did not perform these lifestyle behaviors.
Materials and Methods
Participants
Potential participants were excluded if they: 1- were receiving 
insulin therapy, 2- were participating in exercise ≥2 times per week 
for at least 20 min per session or had undertaken any resistance 
training during the previous six months, 3- reported changes in 
oral hypoglycemic medications during the previous two months, 4- 
reported changes in antihypertensive or lipid-lowering agents in the 
previous month, 5- reported a change of ≥5% in body weight during 
the previous two months, 6- had serum creatinine ≥1.5 mg/dL, 7- had 
proteinuria >1 g/24 h, 8- had blood pressure >160/95 mmHg, 9- had 
physical activity restrictions due to disease, 10- had other medical 
conditions making participation inadvisable, 11- had HbA1c >9.5%, 
12- were smoking, 13- were receiving hormone replacement therapy, 
or 14- had any known microvascular or macrovascular diseases. 
Seventy-five T2DM patients aged between 35 and 70 years, with 
an HbA1c value of 6.5% or above, weight stability (±2 kg) 6 months 
before entry; without restraining orthopedic or neuromuscular 
diseases were assessed for eligibility. The study was approved by 
our institution’s ethics committee and it was conducted in accordance 
with the Declaration of Helsinki.
All participants were asked to revert to their pre-study activity 
levels. They were inactive and none reported previous systematic 
(more than once a week) exercise activity.
Nine of 75 subjects were unwilling to participate following 
completion of the preparation phase of the study (such as filling out 
the questionnaire, dietary assessment, and advice). Sixty-six subjects 
(medical outpatients) were randomized into two groups: aerobic 
exercise training and no exercise (control). Of these, six patients 
dropped out (three from each group) during the experimental 
period due to non-compliance and loss to follow-up. Twenty-nine 
males and 31 females with T2DM completed this study. The aerobic 
exercise and control groups did not differ in clinical or demographic 
characteristics. Eligible patients were interviewed to measure utility 
values, and they were administered the 36-item Short Form Health 
Survey (SF-36) (19) which provides scores on eight areas of functioning 
and well-being (physical functioning, mental health, role physical, role 
emotional, bodily pain, general health, vitality, and social functioning) 
and all items are summed and transformed to form a scale from 0 
to 100. We used the Turkish version of the SF-36 prepared by Kocyigit 
and colleagues (20). A dietitian evaluated the study participants, 
and she prescribed a diet program to all participants according to 
American Diabetes Association recommendations (21). Participants 
were asked to check compliance with the diet at the end of the study.
A total of 60 subjects were receiving blood glucose-lowering 
medication as follows: metformin alone (6 in exercise group, 6 in 
control group); sulfonylurea (1 in the exercise group, 1 in the control 
group); pioglitazone + metformin (4 in the exercise group, 4 in the 
control group); sulfonylurea + metformin (12 in the exercise group, 
11 in the control group); sulfonylurea + pioglitazone (2 in the exercise 
group, 1 in the control group); and pioglitazone + metformin + 
sulfonylurea (5 in the exercise group, 7 in the control group).
All patients completed the SF-36 using the pencil-and-paper 
method in a separate, quiet room while waiting for their turn to 
see the doctor. In order to avoid bias, relatives and friends were 
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9not allowed to be present. On average, each patient took about 
10-15 minutes to complete the SF-36. During the administration of 
the questionnaire, a researcher was readily available for assisting 
the patients in understanding the SF-36 if required. The researchers 
were instructed to minimize their explanations, and the patients were 
asked to answer the questions according to their understanding. 
After completion of the questionnaire, the researcher determined 
the completeness of the returned SF-36s. The participants filled out 
the SF-36 questionnaire again at the end of 12 weeks.
The aerobic exercise group consisted of 30 subjects who took 
part in an exercise-training program. The participants exercised 
on a treadmill three times per week, with training gradually 
progressing in length and intensity. Heart rate monitors were used 
to adjust workloads to achieve target heart rates. The participants 
progressed from 15-20 minutes per session at 60% of maximum 
heart rate to 45 minutes per session at 75% of measured 
maximum heart rate. A personal trainer was present for a 
minimum of three scheduled sessions weekly at each exercise 
facility and supervised the exercise program. After randomization, 
the trainer met each participant individually at least once a week 
for four weeks, then, every two weeks for the subsequent eight 
weeks to ensure appropriate progression through the program. 
The personal trainer monitored attendance and contacted the 
participants if any sessions were missed. Patients, who completed 
fewer than ten of the 12 weeks exercise sessions during the study 
period, were excluded. The control participants were asked to 
revert to their pre-study activity levels, and they continued with 
their normal daily activities during the twelve weeks of research 
without additional guided physical activities. Efforts were made to 
minimize dietary and medication co-intervention. 
Laboratory Tests
Blood samples were obtained from all subjects in the morning 
between 08:00 and 09:00 hours after an overnight fast. 
Measurements were taken on recruitment and repeated after 
twelve weeks. The samples were centrifuged, aliquoted, and 
immediately frozen at -80 °C for analysis of leptin, adiponectin, 
and lipoproteins. 
Serum glucose, total cholesterol (TC), LDL-cholesterol (LDL-c), 
triglyceride (TG), and HDL-cholesterol (HDL-c) levels were measured 
using Randox enzymatic kits in the Roche-Hitachi Modular system. 
LDL-c was calculated by the Friedewald equation method. Leptin 
and adiponectin concentrations in serum were determined using 
a commercially available ELISA kit from RayBiotech (Norcross, GA, 
USA). The intra- and inter-assay coefficients of variation were less 
than 7-10% for all parameters. 
Body weight (kg) and height (cm) of all subjects were measured; 
measurements were taken on recruitment and repeated after 
twelve weeks. Body mass index (BMI) was calculated as weight 
in kilograms divided by the square of height in meters. Waist 
circumference (WC) was measured as the minimum between the 
costal margin and the iliac crest. 
A foot-to-foot body fat analyzer (Tanita TBF 300, Tanita, Tokyo, 
Japan) was used for bioelectrical impedance analysis. Fat 
percentage was recorded before and after twelve weeks. Physical 
examinations included systolic and diastolic blood pressure 
measurement using a mercury sphygmomanometer after a 
10-minute rest. 
Statistical Analysis
The Kolmogorov-Smirnov test was used to determine if continuous 
variables were normally distributed. For normally distributed 
data, results were presented as mean ± standard deviation 
(SD) and comparison between groups of continuous variables 
was performed by using the Student’s t test. When the variables 
were found not to be normally distributed (SF-36, and TG), results 
were given as median ± interquartile range (IQR); comparisons 
between groups of data were made using the Mann-Whitney U 
test. Differences between categorical variables were analyzed 
by the chi-square test (gender and DM treatment). Changes 
in outcome measures were assessed using paired t-test or 
the Wilcoxon-signed ranks test (SF-36, and TG). Relationships 
between variables were analyzed using Pearson’s or Spearman’s 
rank correlation coefficients (SF-36, and TG). Statistical analysis 
was carried out by using Statistical Package of Social Science 
(SPSS), version 16.0 (SPSS Inc., Chicago, IL). A p value of <0.05 was 
considered statistically significant. 
Results
A total of 60 patients, 31 females and 29 males, were included 
in the analysis. HbA1c values, lipid panel values, and baseline 
scores on the SF-36 sub-scales and summary measures are 
shown in Tables 1 and 2.
No exercise-related injuries were reported. Five hypoglycemic 
events were observed immediately post-exercise, which were 
resolved with administration of high-sugar snacks. Exercisers did 
not report hypoglycemia at home or on non-training days. 
The aerobic exercise and control groups did not differ in baseline 
HbA1c, age, gender, percentage of body fat, duration of diabetes, 
BMI, WC, systolic (SAP) and diastolic arterial blood pressure (DAP), 
LDL-c, HDL-c, TG, TC, or leptin and adiponectin levels (Table 1). The 
SF-36 showed no statistically significant differences in baseline 
scores between the control and aerobic exercise groups except 
physical functioning (Table 2). 
The exercise training group completed follow-up over twelve 
weeks, with a 2% weight loss. Lipid profile, BMI, and SAP and DAP 
decreased, but these changes were not statically significant (Table 
3). HbA1c levels also decreased but were not statistically significant 
(7.0±0.8 vs. 6.7±1.0, p=0.079). The levels of WC, leptin, adiponectin 
and percentage of body fat decreased significantly after the 12-
week period in the exercise training group (Table 3; p=0.012, 
0.023, 0.007, 0.048, respectively). Changes in adiponectin levels 
were not associated with changes in any parameter. 
Comparison of initial and terminal SF-36 scores revealed 
significant improvements in the physical functioning and mental 
health subscales in the aerobic exercise group (p=0.020, 0.023, 
respectively). No effects on the other SF-36 parameters were 
noted in that group (Table 4).
Spearman’s correlation analysis revealed that baseline physical 
functioning scores were correlated with mental health (r=0.496, 
p<0.001), physical functioning (r=0.494, p<0.001), bodily pain 
(r=0.584, p<0.001), general health (r=0.512, p<0.001), vitality 
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(r=0.544, p<0.001), social functioning (r=0.416, p=0.001), and role 
emotional (r=0.370, p=0.004) in both groups. 
In both groups, baseline leptin levels were positively correlated 
with percentage of body fat (r=0.530, p<0.001), BMI (r=0.457, 
p<0.001), TC (r=0.301, p=0.021), and LDL-c (r=0.302, p=0.020). 
Baseline leptin levels were negatively correlated with physical 
functioning (r=-0.265, p=0.042), physical problems (r=-0.280, 
p=0.032), bodily pain (r=-0.360 p=0.005), general health 
(r=-0.334, p=0.010), vitality (r=-0.335, p=0.010), role emotional 
(r=-0.261, p=0.046) and mental health (r=-0.292, p=0.025). Baseline 
adiponectin levels were not correlated with any parameters. 
After the 12-week period, Spearman’s correlation analysis revealed 
that physical functioning scores in the aerobic exercise group were 
negatively correlated with HbA1c levels (Figure 1; r=-0.475, p=0.009); 
mental health scores were negatively correlated with LDL-c levels 
(r=-0.391, p=0.044). After the 12-week period, mental health scores 
in the aerobic exercise group were positively correlated with 
physical functioning (r=0.478, p=0.009). 
After the 12-week period, leptin levels in the aerobic exercise 
group were positively correlated with BMI (r=0.303, p=0.021) 
and percentage of body fat (Figure 2, r=0.371, p=0.005); they 
were negatively correlated with physical functioning (r=-0.482; 
p=0.009) and bodily pain (r=-0.540; p=0.003). 
Discussion
Our data show that an aerobic exercise training program induced 
a significant decrease in adiponectin and leptin levels and WC, as 
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Table 2. The difference in the SF-36 between the two groups of patients at baseline
Scale in SF-36 Aerobic Exercise Group (n=30) Control (n=30) p
Physical health component
Physical functioning 85.0±18 60.0±41 0.010*
Physical problems 75.0±50 50.0±75 0.102
Pain 80.0±39 61.5±46 0.074
General health perception 60.0±27 58.5±43 0.425
Mental health component
Vitality 65.0±30 57.5±35 0.235
Social functioning 87.5±25 75.0±38 0.262
Emotional problems 66.6±67 100.0±75 0.402
Mental health 68.0±18 66.0±24 0.761
Data are median ± IQR. Mann-Whitney U test was applied to test for significant differences between groups. *p<0.05 by Mann-Whitney U test 
Table 1. Clinical and laboratory characteristics of aerobic exercise and control group at the baseline period
Variable Aerobic Exercise Group (n=30) Control Group (n=30) p
Age, mean (yrs.) 52.5±7.5 55.5±8.4 0.175
Gender 15 M/15 F 14 M/16 F 0.606
Treatment DM M/S/P+M/S+M/S+P/P+M+S M/S/P+M/S+M/S+P/P+M+S 0.810
Fat percentage (%) 33.4±6.9 33.5±7.5 0.691
HbA1c (%) 7.0±0.8 6.8±1.0 0.181
BMI (kg/m2) 30.8±4.6 30.2±4.5 0.566
WC (cm) 101.9±8.6 99.5±10.7 0.315
SAP (mmHg) 127.6±16.1 127.1±12 0.910
DAP (mmHg) 78.7±9.0 77.6±8.9 0.633
LDL-c (mg/dL) 109.4±36.5 115.0±35.9 0.552
HDL-c (mg/dL) 39.6±12.1 41.0±21.0 0.337
TG (mg/dL)* 143±112 128±97 0.716
TC (mg/dL) 181.5±46.2 186.7±45.3 0.661
Adiponectin (µg/mL) 6.6±0.8 6.5±1.1 0.786
Leptin (ng/mL) 27.1±19.8 26.6±17.5 0.925
Duration of DM (yrs) 6.1±5.2 6.7±4.5 0.634
Chi-square was used to detect differences between groups for gender and DM duration. Results were presented as mean ± SD, and *median ± IQR. P values <0.05 accepted 
as statistically significant
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well as an improvement in physical functioning and mental health 
subscales in sedentary middle-aged type 2 diabetic subjects 
maintaining their usual dietary habits. 
Adiponectin is secreted by visceral adipose tissue rather 
than subcutaneous adipose tissue, and recent studies have 
demonstrated that the visceral fat area is negatively correlated 
with plasma adiponectin levels in obese subjects (22). Furthermore, 
visceral adipose tissue, not total adipose tissue, plays an 
important role in pathogenesis of insulin resistance, T2DM, and 
cardiovascular disease (23,24). Circulating levels of adiponectin 
may be a link between visceral obesity and certain related metabolic 
abnormalities that contribute to the development of insulin 
resistance, T2DM, and atherosclerosis (25,26,27). Adiponectin 
levels have been reported to be inversely correlated with central 
adipose tissue stores. The marked reduction in WC induced by our 
training program was associated with a decrease in adiponectin 
levels. These findings suggest that decreased adiponectin levels 
may be because of the increases in proinflammatory cytokines (28), 
such as inteleukin-6, tumor necrosis factor-α and adrenaline, or 
ethnicity discrepancy, in the post-exercise period (29). The reasons 
for these discordant findings are not clear. 
In recent years, various authors have emphasized that increased 
adiponectin levels may not always be beneficial in terms of 
good health (30,31). Hadjadj et al. reported increased levels of 
adiponectin associated with diabetes-related microvascular 
complications (30). Dekker et al. found that high adiponectin serum 
levels predict all-cause and cardiovascular disease mortality (31).
On the other hand, we found a relationship between leptin and the 
percentage of body fat and BMI in the exercise training group. This is 
in agreement with a number of studies that have shown decreases in 
leptin levels in response to weight loss, lower percentage of body fat, 
and decreased WC. In general, post-exercise decreases in leptin can 
Turk Jem 2015; 19: 7-13
Doğan Dede et al.
Influence of Exercise in Type 2 Diabetes
Table 4. The difference in the SF-36 baseline and after 12 weeks period in aerobic exercise group (median ± IQR)
Scale in SF-36 Before Exercise (n=30) After Exercise (n=30) p
Physical Health Component
Physical functioning 85.0±18 90.0±20 0.020β
Physical problems 75.0±50 100.0±25 0.367
Pain 80.0±39 74.0±38 0.936
General health perception 60.0±27 62.0±34 0.267
Mental Health Component
Vitality 65.0±30 70.0±28 0.216
Social functioning 87.5±25 87.5±25 0.776
Emotional problems 66.6±67 66.6±67 0.346
Mental health 68.0±18 72.0±20 0.023β
βStatistical difference compared to pre-test values of variables in aerobic exercise group of diabetic patients (Wilcoxon signed ranks test (SF-36); p<0.05)
Table 3. Comparisons of clinical and laboratory characteristics baseline and after 12 weeks period in aerobic exercise and control group (mean 
± SD or median (min-max))
Variable Baseline Aerobic 
Exercise Group (n=30)
After 12 weeks Period in 
Aerobic Exercise Group (n=30)
Baseline Control
Group (n=30)
After 12 weeks Period in 
Control Group (n=30)
p^ p*
HbA1c (%) 7.0±0.8 6.7±1.0 6.8±1.0 6.8±1.0 0.079 0.608
BMI (kg/m2) 30.9±4.6 30.0±4.5 30.2±4.5 30.9±4.7 0.289 0.548
WC (cm) 101.9±8.6 100.0±8.2 100.7±10.2 101±9.9 0.012β 0.631
Fat percentage% 32.5 ±7.7 31.6±8.0 34.2±6.9 34.5±6.6 0.048β 0.267
SAP (mmHg) 127.6±16.1 122.0±12.2 127.2±12.1 124.5±15.6 0.112 0.331
DAP (mmHg) 78.7±9.0 76.5±8.2 77.7±9.0 76.7±8.1 0.240 0.536
LDL-c (mg/dL) 109.4 ± 36.5 102.9±25.2 114.1±36.2 115.3±34.0 0.299 0.877
HDL-c (mg/dL) 40.7±12.8 38.6±7.6 43.5±9.9 41.4±10.4 0.372 0.274
TG (mg/dL)† 143±112 124±96 128±97 138±128 0.182 0.473
TC (mg/dL) 181.5±46.2 172.8±32.6 185.5±45.6 186.6±48.6 0.120 0.880
Adiponectin (µg/mL) 6.6±0.8 6.0±0.8 6.6±1.2 6.4±1.0 0.007β 0.275
Leptin (ng/mL) 26.6±20.5 23.8±19 26.6±17.6 27.9±16.7 0.023β 0.491
Results were presented as mean ± SD, and †median ± IQR. p^ Before vs after 12 weeks period in aerobic exercise group. p* Before vs after 12 weeks period in control group. 
βStatistical difference compared to pre-test values of dependent variables in aerobic exercise group of diabetic patients (paired t-test and Wilcoxon signed ranks test (TG); 
p<0.05)
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be observed if energy expenditure is high. In our study, BMI decreased 
after the 12 week-period in the exercise-training group, but these 
changes were not statically significant. The levels of WC and leptin 
decreased in spite of a significant decrease in serum adiponectin 
levels. Leptin levels were positively correlated with BMI and negatively 
with physical functioning and pain. As in our study, Gomez-Merino 
et al. reported a reduction in leptinemia after three weeks of military 
training, but body weight remained stable (32). Ishii et al. showed a 
reduction in leptinemia after six weeks of aerobic training in type 2 
diabetic subjects (33). As with fat percentage, expected associations 
between physical activity and leptin were observed. Thus, our study 
supports a potential link between reduced leptin levels and elevated 
physical activity levels in patients with T2DM. 
We found significantly lower leptin levels after exercise, and we 
concluded that regular exercise, by reducing WC and percentage 
of body fat, suppresses serum leptin levels. This decrease 
appeared despite the absence of significant changes in BMI. 
There is, however, a wide variation in serum leptin levels among 
individuals with similar BMI or fat mass (34,35,36) indicating that 
there are also other modifiers of serum leptin levels.
Physical exercise affects hormonal concentrations (insulin, 
cortisol, growth hormone, catecholamines, testosterone, etc.) 
and metabolites (free fatty acids, lactic acid, triglycerides, etc.). 
For these reasons, we believe that physical exercise and training 
could modify leptin response, depending on several factors. 
After the 12-week period, mental health scores in the aerobic 
exercise group were positively correlated with physical functioning. 
Thus, high physical activity is viewed as a consequence of cognitive 
processing. A number of studies have indicated that physical 
activity can prevent or reduce mental health problems (typically, 
anxiety and depression) and that physically active adolescents are 
less likely to suffer from these mental health problems (37,38,39).
In our study, we found that mental health scores were negatively 
correlated with LDL-c levels in the exercise-training group after the 
12-week period. However, whether low-serum cholesterol levels 
may cause adverse effects on mental health remains unclear (40). 
Strandberg et al. found, with 39 years of follow-up, that men with 
the lowest serum cholesterol levels have longer survival rates, 
better physical function, and QOL, along with no adverse effect 
on mental health (41). 
It is generally known that the overall QOL in patients with diabetes 
mellitus is poorer than in the normal population, however, the 
extent of this decline related to the level of glycemic control remains 
debatable, as results from previous studies have been inconsistent 
(17,18). After 12 weeks, we found that patients in the exercise training 
group who reported better physical functioning and vitality were more 
likely to have decreased HbA1c levels. Higher glycemic levels were 
associated with lower well-being scores (42). Improved QOL was 
positively associated with a decrease in hyperglycemic incidences, 
which may be a reflection of better glycemic control (17,43). Whether 
measures to improve physical functioning and vitality would help to 
improve glycemic control may be an area for future studies. 
Improved diabetic control through aerobic exercise training is 
associated with improved mental and physical functioning and is 
related to a decrease in adiponectin and leptin levels. Improvement 
in physical functioning and mental health and amelioration of 
glycemic status may result in an improvement of physical QOL.
A limitation of our study is that there was a lack of multi-isoforms 
and receptors of adiponectin. The high molecular weight isoform 
has been shown to be the active form and, therefore, may be 
determined to identify the beneficial health effects of endurance 
training in T2DM. Our results may be explained by different 
adiponectin isoforms or the expression of adiponectin receptors. 
Finally, aerobic exercise training may bring about significant 
beneficial effects including a decrease in serum adiponectin 
and leptin and an improvement in body fat, glycemic status, and 
physical and mental QOL in type 2 diabetic individuals.
Larger, longer-term cohort studies are needed to further evaluate the 
relationship between glycemic control and QOL. Physicians should 
be aware of physical and mental QOL in the management of T2DM. 
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Figure 1. Physical functioning scores were negatively correlated with 
HbA1c levels after 12 weeks period in aerobic exercise group
Figure 2. After 12 weeks period in aerobic exercise group, leptin levels 
were correlated with the percentage of body fat
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